BBIO GlobeNewswire 2 days ago BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
BBIO Insider Monkey 3 days ago BridgeBio (BBIO) Soars 13% on Double-Digit Price Target Upgrade 📈 AI Sentiment Highly Positive 10/10
BBIO Investor's Business Daily 3 days ago Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up
BBIO The Fly 4 days ago Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls 📈 AI Sentiment Highly Positive 8/10
BBIO MT Newswires 4 days ago William Blair Initiates BridgeBio Pharma at Outperform 📈 AI Sentiment Highly Positive 8/10